Intra-cardiac echocardiography in alcohol septal ablation: A prospective comparative study against trans-thoracic echocardiography

被引：10

作者：

Cooper R.M. ^{[1
]}

Shahzad A. ^{[1
]}

Newton J. ^{[2
]}

Vejlstrup N. ^{[3
]}

Axelsson A. ^{[3
]}

Sharma V. ^{[4
]}

Ormerod O. ^{[2
]}

Stables R.H. ^{[1
]}

机构：

[1] Institute of Cardiovascular Medicine and Science, Liverpool Heart and Chest Hospital, Thomas Drive, Liverpool

[2] Oxford John Radcliffe Hospital, Oxford

[3] Rigshospitalet, Copenhagen

[4] Royal Liverpool University Hospital, Liverpool

来源：

Echo Research & Practice | 2015年 / 2卷 / 1期

关键词：

Alcohol septal ablation; Hypertrophic obstructive cardiomyopathy; Non-surgical septal reduction therapy;

D O I：

10.1530/ERP-15-0002

中图分类号：

学科分类号：

摘要：

Alcohol septal ablation (ASA) in hypertrophic obstructive cardiomyopathy reduces left ventricular outflow tract gradients. A third of patients do not respond; inaccurate localisation of the iatrogenic infarct can be responsible. Transthoracic echocardiography (TTE) using myocardial contrast can be difficult in the laboratory environment. Intra-cardiac echocardiography (ICE) provides high-quality images. We aimed to assess ICE against TTE in ASA. The ability of ICE and TTE to assess three key domains (mitral valve (MV) anatomy and systolic anterior motion, visualisation of target septum, adjacent structures) was evaluated in 20 consecutive patients undergoing ASA. Two independent experts scored paired TTE and ICE images off line for each domain in both groups. The ability to see myocardial contrast following septal arterial injection was also assessed by the cardiologist performing ASA. In patients undergoing ASA, ICE was superior in viewing MV anatomy (P=0.02). TTE was superior in assessing adjacent structures (P=0.002). There was no difference in assessing target septum. Myocardial contrast: ICE did not clearly identify the area of contrast in 17/19 patients due to dense acoustic shadowing (8/19) and inadequate opacification of the myocardium (6/19). ICE only clearly localised contrast in 2/19 cases. ICE does not visualise myocardial contrast well and therefore cannot be used to guide ASA. TTE was substantially better at viewing myocardial contrast. There was no significant difference between ICE and TTE in the overall ability to comment on cardiac anatomy relevant to ASA. © 2015 The authors.

引用

页码：9 / 17

页数：8

共 27 条

[1]

Elliott P., McKenna W.J., Hypertrophic cardiomyopathy, Lancet, 363, pp. 1881-1891, (2004)

[2]

Maron M.S., Olivotto I., Betocchi S., Casey S.A., Lesser J.R., Losi M.A., Cecchi F., Maron B.J., Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy, New England Journal of Medicine, 348, pp. 295-303, (2003)

[3]

Maron M.S., Olivotto I., Zenovich A.G., Link M.S., Pandian N.G., Kuvin J.T., Nistri S., Cecchi F., Udelson J.E., Maron B.J., Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction, Circulation, 114, pp. 2232-2239, (2006)

[4]

Sorajja P., Ommen S.R., Holmes D.R., Dearani J.A., Rihal C.S., Gersh B.J., Lennon R.J., Nishimura R.A., Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy, Circulation, 126, pp. 2374-2380, (2012)

[5]

Jensen M.K., Prinz C., Horstkotte D., Van Buuren F., Bitter T., Faber L., Bundgaard H., Alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: Low incidence of sudden cardiac death and reduced risk profile, Heart, 99, pp. 1012-1017, (2013)

[6]

Nagueh S.F., Groves B.M., Schwartz L., Smith K.M., Wang A., Bach R.G., Nielsen C., Leya F., Buergler J.M., Rowe S.K., Et al., Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy a multicenter North American registry, Journal of the American College of Cardiology, 58, pp. 2322-2328, (2011)

[7]

Jensen M.K., Almaas V.M., Jacobsson L., Hansen P.R., Havndrup O., Aakhus S., Svane B., Hansen T.F., Kober L., Endresen K., Et al., Long-term outcome of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: A Scandinavian multicenter study, Circulation. Cardiovascular Interventions, 4, pp. 256-265, (2011)

[8]

Sherrid M.V., Chaudhry F.A., Swistel D.G., Obstructive hypertrophic cardiomyopathy: Echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction, Annals of Thoracic Surgery, 75, pp. 620-632, (2003)

[9]

Van Dockum W.G., Ten Cate F.J., Ten Berg J.M., Beek A.M., Twisk J.W., Vos J., Hofman M.B., Visser C.A., Van Rossum A.C., Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Evaluation by contrast-enhanced magnetic resonance imaging, Journal of the American College of Cardiology, 43, pp. 27-34, (2004)

[10]

Amano Y., Kitamura M., Yamada F., Aita K., Takayama M., Tachi M., Kumita S., Magnetic resonance imaging of microvascular obstruction in hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation, Acta Radiologica, (2014)

← 1 2 3 →